Original Article

Evaluation of IGF1/IGFBP3 Molar Ratio as an Effective Tool for Assessing the Safety of GH Therapy in Small-for-Gestational-Age, GH-Deficient and Prader-Willi Children
  • Meriem Gaddas
  • Laurence Périn
  • Yves Le Bouc
J Clin Res Pediatr Endocrinol 0; 0: 0-0 [e-Pub] DOI: 10.4274/jcrpe.galenos.2019.2018.0277
Neonatal Features of the Prader-Willi Syndrome; The Case for Making the Diagnosis During the First Week of Life
  • Filiz Mine Çizmecioğlu
  • Jeremy Huw Jones
  • Wendy Forsyth Paterson
  • Sakina Kherra
  • Mariam Kourime
  • Ruth McGowan
  • M. Guftar Shaikh
  • Malcolm Donaldson
J Clin Res Pediatr Endocrinol 2018; 10: 264-273 DOI: 10.4274/jcrpe.0029 PMID:29553044


Syndromic Disorders with Short Stature
  • Zeynep Şıklar
  • Merih Berberoğlu
J Clin Res Pediatr Endocrinol 2014; 6: 1-8 DOI: 10.4274/Jcrpe.1149 PMID:24637303
Prader-Willi Syndrome and Growth Hormone Deficiency
  • Zehra Aycan
  • Veysel Nijat Baş
J Clin Res Pediatr Endocrinol 2014; 6: 62-67 DOI: 10.4274/jcrpe.1228 PMID:24932597


Different Genotypes in Prader-Willi Syndrome
  • Yasemin Kendir Demirkol
  • Gülşen Akay Tayfun
  • Huriye Nursel Elçioğlu
J Clin Res Pediatr Endocrinol 2015; 7: 85-85

About Journal


Useful Links